ImmuCell (ICCC) Q2 2026 Earnings Call: Sales Rise 11.5%, Capacity Expansion Planned
Source Tradingkey
Key Takeaways
- Q2 2026 product sales increased 11.5% year over year to $7.2 million, despite comparison with Q2 2025 distributor restocking following the resolution of backorders.
- Domestic sales rose 27.7% to $6.2 million, while international sales declined 38.9% to approximately $1 million, primarily due to Canada and the prior-year backorder clearance.
- Gross margin fell to 33.9% from 43.7% a year earlier. Lower manufacturing output, approximately $150,000 of material-related scrap and the shift of former Re-Tain costs into cost of goods sold pressured profitability.
- Q2 net income was $1.8 million, or $0.20 per share, compared with $500,000, or $0.06 per share, in Q2 2025. The 2026 result included a $2 million settlement with the former Re-Tain contract manufacturer.
- First Defense’s U.S. market share among animals receiving a biological scours preventative increased from approximately 15% in December 2025 to 19% at the end of June 2026.
- ImmuCell plans to invest approximately $8 million in freeze-drying and liquids processing capacity. Management expects the expansion to more than triple current capacity and reduce total processing time to less than one month.
Core Financial Data
| Metric | Q2 2026 | Q2 2025 | Change / context |
|---|---|---|---|
| Product sales | $7.2 million | — | Up 11.5% year over year |
| Domestic sales | $6.2 million | — | Up 27.7% |
| International sales | Approximately $1 million | — | Down 38.9% |
| Gross margin | 33.9% | 43.7% | Down 9.8 percentage points |
| Sales, marketing and administrative expenses | $2.4 million | $1.4 million | Higher leadership and commercial investment |
| Product development expenses | Approximately $120,000 | Approximately $800,000 | Lower Re-Tain development spending and cost reclassification |
| Net income | $1.8 million | $500,000 | Includes a $2 million settlement in Q2 2026 |
| Diluted earnings per share | $0.20 | $0.06 | Includes settlement benefit |
| Adjusted EBITDA | $2.7 million | $1.4 million | Includes the $2 million settlement in 2026 |
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
As of the European session on August 14, international spot copper prices (COPPER) continued to fluctuate near historical highs, trading around $14,070, down slightly by 0.3% intraday. De
WTI remains below $80.50 as traders monitor diplomatic efforts to reopen HormuzWest Texas Intermediate (WTI) oil price remains subdued for the third successive day, trading around $80.30 per barrel during the Asian hours on Friday. Crude oil prices edge lower as investors adopt a wait-and-see approach, closely monitoring diplomatic attempts to reopen the Strait of Hormuz.
West Texas Intermediate (WTI) oil price remains subdued for the third successive day, trading around $80.30 per barrel during the Asian hours on Friday. Crude oil prices edge lower as investors adopt a wait-and-see approach, closely monitoring diplomatic attempts to reopen the Strait of Hormuz.
Here is what you need to know on Thursday, August 13:
WTI declines below $82.50 as oil inventories rise far more than expectedWest Texas Intermediate (WTI), the US crude oil benchmark, is trading around $82.45 during the early Asian trading hours on Thursday. WTI declines on a larger-than-expected build in US crude oil inventories. Traders will closely monitor the developments surrounding US-Iran talks for fresh impetus.
West Texas Intermediate (WTI), the US crude oil benchmark, is trading around $82.45 during the early Asian trading hours on Thursday. WTI declines on a larger-than-expected build in US crude oil inventories. Traders will closely monitor the developments surrounding US-Iran talks for fresh impetus.
During Wednesday's Asian trading session, spot gold (XAUUSD) extended its rebound, reclaiming $4,400/oz. As of 11:08 Beijing time on August 12, spot gold was trading at $4,414.705/oz, up
